机构：[1]Eye Institute, Eye & ENT Hospital, Fudan University, Shanghai, China. zhuxiangjia1982@126.com.[2]NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China. zhuxiangjia1982@126.com.[3]Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China. zhuxiangjia1982@126.com.[4]Eye Institute, Eye & ENT Hospital, Fudan University, Shanghai, China.[5]NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.[6]Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China.[7]Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.首都医科大学附属北京同仁医院研究所眼科研究所[8]Center for Biomedicine and Innovations, Faculty of Medicine, Macau University of Science and Technology and University Hospital, Macau, China.[9]Guangzhou KangRui Biological Pharmaceutical Technology Company, Guangzhou, China.[10]Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.[11]Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.[12]Department of Radiology, Eye & ENT Hospital, Fudan University, Shanghai, China.[13]Center for Biomedical Imaging, Fudan University, Shanghai, China.[14]State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China.[15]Sichuan Provincial Key Laboratory for Human Disease Gene Study and the Center for Medical Genetics, Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology, Chengdu, China. zliny@yahoo.com.四川省人民医院[16]Research Unit for Blindness Prevention of Chinese Academy of Medical Sciences (2019RU026), Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, Sichuan, China. zliny@yahoo.com.四川省人民医院[17]Center for Biomedicine and Innovations, Faculty of Medicine, Macau University of Science and Technology and University Hospital, Macau, China. kang.zhang@gmail.com.[18]Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. kang.zhang@gmail.com.[19]Guangzhou HuiBoRui Biological Pharmaceutical Technology Co., Ltd, Guangzhou, China. kang.zhang@gmail.com.[20]Eye Institute, Eye & ENT Hospital, Fudan University, Shanghai, China. luyieent@126.com.[21]NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China. luyieent@126.com.[22]Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China. luyieent@126.com.
第一作者机构：[1]Eye Institute, Eye & ENT Hospital, Fudan University, Shanghai, China. zhuxiangjia1982@126.com.[2]NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China. zhuxiangjia1982@126.com.[3]Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China. zhuxiangjia1982@126.com.
共同第一作者：
推荐引用方式(GB/T 7714)：
Zhu Xiangjia,Du Yu,Li Dan,et al.Author Correction: Aberrant TGF-β1 signaling activation by MAF underlies pathological lens growth in high myopia[J].Nature communications.2022,13(1):7834.doi:10.1038/s41467-022-35562-1.
APA：
Zhu Xiangjia,Du Yu,Li Dan,Xu Jie,Wu Qingfeng...&Lu Yi.(2022).Author Correction: Aberrant TGF-β1 signaling activation by MAF underlies pathological lens growth in high myopia.Nature communications,13,(1)
MLA：
Zhu Xiangjia,et al."Author Correction: Aberrant TGF-β1 signaling activation by MAF underlies pathological lens growth in high myopia".Nature communications 13..1(2022):7834
综合性期刊